NYSE · Health care

Cadre Holdings, Inc. (CDRE)

Cadre Holdings, Inc. brought in $732.7M of revenue over the twelve months to September 30, 2026, up 18.3% from a year earlier. Net income was $41.1M, a net margin of 5.6%. Operating cash flow minus capital spending left $56.8M of free cash flow in fiscal 2025. At September 30, 2026 it held $63.9M in cash against $369.5M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 4, 2026.

Watch CDRE in 60 seconds

Price

$33.44

-2.18% on the day · November 10, 2026

52-week range $24.07 to $48.76

Market cap

$1.4B

Revenue (last 12 months)

$732.7M

+18.3% year on year

Net margin

5.6%

P/E

32.8

on FY2025 diluted EPS

Key facts about Cadre Holdings, Inc.

Net worth: Cadre Holdings, Inc. has a market value (market cap) of $1.4B at the latest share price, and shareholders' equity of $366.8M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit: In fiscal 2025 revenue was $610.3M (+7.5% year on year), with net income of $44.1M. Over the 12 months to September 30, 2026: revenue $732.7M, net income $41.1M.
Cash flow: In fiscal 2025 operations brought in $63.7M of cash; after $6.9M of capital spending, free cash flow was $56.8M.
Latest report: The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 4, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
Next earnings report: Cadre Holdings, Inc.'s next report is expected around March 9, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Dividend: Cadre Holdings, Inc. declared dividends of $0.10 per share in fiscal 2025, a yield of 0.28% at the current price.

What Cadre Holdings, Inc. does

Cadre Holdings, Inc. is registered with the SEC under industry code SIC 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies). Its shares trade on NYSE under the ticker CDRE.

Revenue and profit by year

Revenue

Net income

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal year	Revenue	Operating income	Net income	Diluted EPS	Free cash flow
2025	$610.3M	$67.4M	$44.1M	$1.02	$56.8M
2024	$567.6M	$66.8M	$36.1M	$0.90	$26.1M
2023	$482.5M	$56.5M	$38.6M	$1.02	$66.5M
2022	$457.8M	$16.7M	$5.8M	$0.16	$41.9M
2021	$427.3M	$51.7M	$12.7M	$0.44	$37.3M
2021	$404.6M	$49.8M	$38.5M	$1.40	$40.7M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around March 9, 2027.

Estimated from its filing rhythm: 52 weeks after its report of March 10, 2026. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where CDRE ranks in Health care

Revenue$610.3M

#189 of 751 in Health care · Top 25%

Revenue growth+7.5%

#316 of 532 in Health care · Bottom 41%

Net margin7.2%

#141 of 544 in Health care · Top 26%

Free cash flow margin9.3%

#132 of 490 in Health care · Top 27%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Dividends

Cadre Holdings, Inc. declared $0.10 per share in fiscal 2025. At the current price that is a yield of 0.28%. It paid out $15.4M in cash dividends, 35% of its net income.

Fiscal year	Per share	Paid out	Of profit
2025	$0.10	$15.4M	35%
2024	$0.09	$13.9M	39%
2023	$0.08	$12M	31%
2022	$0.08	$11.5M	198%
2021	n/a	$12.8M	101%

Per share as declared (or paid, where only that is reported), adjusted for stock splits the company itself restated. Yield is the latest fiscal year's dividend over the current price.

Latest SEC filings

What Cadre Holdings, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

November 4, 2026
Quarterly report 10-Q · period to September 30, 2026Revenue rose 30% to $202.9M versus the same quarter last year; diluted EPS $0.37 versus $0.27.
November 4, 2026
Quarterly results 8-K
September 30, 2026
Activist stake changed SCHEDULE 13D/A
August 7, 2026
Quarterly results 8-K/A
August 6, 2026
Passive stake changed SCHEDULE 13G/A
August 5, 2026
Merger registration (amended) S-4/A
August 5, 2026
Quarterly report 10-Q · period to June 30, 2026Revenue rose 32% to $207.1M versus the same quarter last year; diluted EPS $0.26 versus $0.30.
August 5, 2026
Quarterly results 8-K
July 29, 2026
Material agreement 8-K
June 18, 2026
Activist stake changed SCHEDULE 13D/A

Recent insider filings (Forms 3, 4 and 144): 10, the latest on August 26, 2026. Insider transactions on SEC

What is CDRE worth? A DCF from its reported cash flow

Insider trades

What the people running Cadre Holdings, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders sold $9.5M worth of shares in the last 90 days and bought none on the open market.

Bought (open market)

last 90 days

Sold

$9.5M

last 90 days

Net sold

288,742

$9.5M

Date	Insider	What	Shares	Price	Value	Filing
August 25, 2026	Kanders Warren BCEO AND CHAIRMAN, Director, 10% owner	Soldindirect	55,345	$31.54	$1.7M	Form 4
August 25, 2026	Kanders Warren BCEO AND CHAIRMAN, Director, 10% owner	Soldindirect	44,655	$32.28	$1.4M	Form 4
August 24, 2026	Kanders Warren BCEO AND CHAIRMAN, Director, 10% owner	Soldindirect	65,431	$33.20	$2.2M	Form 4
August 24, 2026	Kanders Warren BCEO AND CHAIRMAN, Director, 10% owner	Soldindirect	34,569	$33.65	$1.2M	Form 4
August 17, 2026	Williams BradPRESIDENT	Exercised options	42,770	$23.45	$1M	Form 4
August 17, 2026	Williams BradPRESIDENT	Exercised options	45,972	$20.53	$943.8K	Form 4
August 17, 2026	Williams BradPRESIDENT	Sold	104	$34.34	$3.6K	Form 4
August 17, 2026	Williams BradPRESIDENT	Sold	88,638	$33.24	$2.9M	Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns CDRE

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Holder	Of class	Shares	Filed
Warren B. Kanders13D, may seek influence with 1 related filers	25.8%	11,117,928	September 30, 2026
Fmr LLC13G, passive with 1 related filers	5.8%	2,475,623	August 6, 2026
Reinhart Partners, LLC.13G, passive	5.3%	2,170,349	February 12, 2026

Latest filings below 5%: Capital International Investors 3% (May 14, 2026).

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 156 managers reported a position.

Holder	Shares	Value	Change on quarter
BlackRock, Inc.	2,936,878	$83.7M	+310,495
Greenhouse Funds LLLP	2,868,664	$81.8M	+286
Reinhart Partners, LLC.	2,738,373	$78.1M	+500,476
Fmr LLC	2,475,623	$70.6M	-843,573
State Street Corp	1,949,734	$55.6M	+553,411
Capital International Investors	1,622,466	$46.3M	+361,660
Vanguard Capital Management LLC	1,324,254	$37.8M	+76,805
Capital World Investors	1,205,237	$34.4M	+32,880
Wynnefield Capital Inc	1,205,000	$34.4M	+55,000
Select Equity Group, L.P.	1,181,921	$33.7M	+433,423
Brown Advisory Inc	986,269	$28.1M	+130,315
Dimensional Fund Advisors LP	828,520	$23.6M	+61,447
Geode Capital Management, LLC	773,516	$22.1M	+86,662
Morgan Stanley	729,641	$20.8M	-22,155
Capital Research Global Investors	686,030	$19.6M	+97,740
Bank of America Corp	665,870	$19M	+103,092
First Eagle Investment Management, LLC	612,916	$17.5M	new
Catawba River Capital	597,872	$17M	+337,554
Raymond James Financial Inc	409,158	$11.7M	-98,080
Invesco Ltd.	333,171	$9.5M	+43,353

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

3 insiders reported holding 19,332,353 shares in total, about $646.4M at the last price.

Holder	Shares	As of
Kanders Warren BCEO AND CHAIRMAN, Director, 10% owner	19,018,82318,968,647 held indirectly	August 25, 2026
Williams BradPRESIDENT	172,932	August 17, 2026
Browers BlaineCHIEF FINANCIAL OFFICER	140,598	March 18, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about CDRE

What does Cadre Holdings, Inc. do?

Cadre Holdings, Inc. is a company in the Health care sector, listed on NYSE as CDRE. Its shares trade on NYSE under the ticker CDRE.

What is Cadre Holdings, Inc.'s net worth?

Cadre Holdings, Inc. has a market value (market cap) of $1.4B at the latest share price, and shareholders' equity of $366.8M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Cadre Holdings, Inc. profitable?

Yes. Over the twelve months to September 30, 2026 it reported net income of $41.1M on revenue of $732.7M, a net margin of 5.6%.

How much revenue does Cadre Holdings, Inc. make?

Over the twelve months to September 30, 2026 Cadre Holdings, Inc. reported revenue of $732.7M. That is 18.3% more than a year earlier.

When did Cadre Holdings, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on November 4, 2026. It covers the period to September 30, 2026.

When is Cadre Holdings, Inc.'s next earnings report?

Cadre Holdings, Inc.'s next report is expected around March 9, 2027. That is an estimate from its filing rhythm, not a date the company has announced.

Does Cadre Holdings, Inc. pay a dividend?

Yes. Cadre Holdings, Inc. declared dividends of $0.10 per share in fiscal 2025, a yield of 0.28% at the current price.

Similar companies

ENOV

Enovis CORP

AVR

Anteris Technologies Global Corp.

ESTA

Establishment Labs Holdings Inc.

Jin Medical International Ltd.

Compare CDRE with

Compare CDRE with any company

Follow CDRE

Get an email when Cadre Holdings, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Where the numbers come from

Financial figures are the values Cadre Holdings, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.